Navigating the Passage for Better Understanding and Prognosis for Acute Limb Ischemia After Lower-Extremity Revascularization

Circulation. 2021 Dec 7;144(23):1842-1844. doi: 10.1161/CIRCULATIONAHA.121.057577. Epub 2021 Dec 6.

Authors

Mette Søgaard^{1

2}, Nikolaj Eldrup³, Peter Brønnum Nielsen^{1

2}

Affiliations

¹ Department of Cardiology, Aalborg University Hospital, Denmark (M.S., P.B.N.).
² Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Faculty of Health, Aalborg University, Denmark (M.S., P.B.N.).
³ Department of Vascular Surgery, Rigshospitalet, Copenhagen University, Denmark (N.E.).

PMID: 34871108
DOI: 10.1161/CIRCULATIONAHA.121.057577

No abstract available

Keywords: Editorials; acute limb ischemia; anticoagulation; peripheral arterial disease; rivaroxaban.

Publication types

Editorial
Comment

MeSH terms

Humans
Ischemia* / diagnosis
Ischemia* / etiology
Lower Extremity*
Prognosis